Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00786630 · ClinicalTrials.gov registry record · NA

Intervention to Reduce Injection Drug Use

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
726
Enrollment target

NCT00786630 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 726 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00786630, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
726 participants
Enrollment target

Study Summary

This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the behaviors associated with HIV and HCV risk among injection drug users (IDUs) and to improve client overall functioning. The overall goal of this project is to compare strengths-based case-management (CM) to an enhanced version of CM that uses case managers to facilitate a therapeutic alliance (CM/FTA) among out-of-treatment IDUs in Denver.

Interventions

  • BEHAVIORAL Strengths-based case management
  • BEHAVIORAL Case management plus facilitated treatment alliance

Trial Details

FieldValue
Enrollment Target 726 participants
Start Date 2007-11
Est. Completion 2013-02
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT00786630

The ClinicalTrials.gov registry entry for NCT00786630 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 726 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Strengths-based case management is the first listed.

NCT00786630 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00786630 about?

NCT00786630 is a clinical study titled "Intervention to Reduce Injection Drug Use". This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the behaviors associated with HIV and HCV risk among injection drug users (IDUs) and to improve client overall functi...

What is the current status of trial NCT00786630?

This trial is currently completed. It is a NA study. The enrollment target is 726 participants. The study started on 2007-11. Estimated completion is 2013-02.

What interventions are being tested in trial NCT00786630?

The interventions under investigation include: Strengths-based case management (BEHAVIORAL), Case management plus facilitated treatment alliance (BEHAVIORAL).

Who is sponsoring clinical trial NCT00786630?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.